查詢結果分析
相關文獻
- 某醫院產前血清篩檢調查
- 臺灣新生兒B型肝炎疫苗政策之直接成本分析
- 2017年首例新生兒聽損確診個案經主動監視確診先天性德國麻疹症候群病例事件報告
- 境外移入先天性德國麻疹症候群病例事件報告
- 由兩起外籍學生德國麻疹群聚事件檢討德國麻疹之政策意涵
- 接種兩劑MMR疫苗後之懷孕婦女德國麻疹抗體分析
- 臺灣地區懷孕婦女的德國麻疹抗體陽性率及IgG濃度分析
- 慢性B型肝炎之治療
- Comparison of Immunogenicity of Simultaneous and Nonsimultaneous Vaccination with MMR and JE Vaccine Among 15-month-old Children
- B型肝炎帶原的中醫療法
頁籤選單縮合
| 題 名 | 某醫院產前血清篩檢調查=Prenatal Serum Test Survey at a Hospital |
|---|---|
| 作 者 | 呂旭峰; 曾鈺婷; 蔡惠貞; 孫吉珍; 劉啓明; 李美慧; 方宇; | 書刊名 | Journal of Biomedical & Laboratory Sciences |
| 卷 期 | 18:1-4 2006[民95] |
| 頁 次 | 頁7-14 |
| 分類號 | 415.124 |
| 關鍵詞 | 德國麻疹; B型肝炎; 疫苗政策; Rubella; Hepatitis B; Vaccination policy; |
| 語 文 | 中文(Chinese) |
| 中文摘要 | 本研究於2003年7月至2005年10月針對至醫院健檢的2254人次孕婦進行懷孕8個月的5項血清產前 篩檢調查,項目包括rapid plasma reagin test (RPR)、anti-human immunodeficiency virus (anti-HIV)、rubella immunoglobulin G (rubella IgG) 、hepatitis B external antigen (HBeAg)、 hepatitis B surface antigen (HBsAg),陽性率分別為 0.177%(4/2,254)、 0.044%(1/2,254) 、 94%(2109/2,254)、2.4%(54/2,254)與11.8%(266/2,254)。孕婦產前篩檢RPR若陽性,其嬰兒RPR 陽性率將高達75%。17-34歲孕婦血清的德國麻疹IgG陽性率95.6% (1641/1717)高於35-48歲孕婦 的陽性率87.2% (468/537)(χ2 test, p<0.05),>25歲者其HBsAg帶原者陽性率明顯高於<25歲者,可 見B型肝炎與德國麻疹的疫苗政策確實具成效。 |
| 英文摘要 | This study aimed to survey and assess the results of rapid plasma reagin test (RPR), anti-human immunodeficiency virus (anti-HIV), rubella immunoglobulin G (rubella IgG), hepatitis B external antigen (HBeAg), hepatitis B surface antigen (HBsAg) detected in 2254 pregnant women at the eighth month of pregnancy during a period from July 2003 to October 2005 in this hospital. The positive rates were 0.177% (4/2254), 0.044% (1/2,254), 94% (2109/2254), 2.4% (54/2254) and 11.8% (266/2254) respectively. Infants from those mothers with positive RPR showed a high positive rate of 75%. The positive rates of serum rubella IgG for pregnant women aged 17-34 (95.6%, 1641/1717) were higher than those for aged 35-48 (87.2%, 468/537) )(χ2 test, p<0.05). The positive rates of HBsAg were also higher in the age group of more than 25 years old, compared to those under 25 years of age. It is concluded that the vaccination policy against hepatitis B and rubella helps to reduce the prevalence rates with expected efficacy. |
本系統中英文摘要資訊取自各篇刊載內容。